Greenleaf Trust’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$669K Buy
1,129
+27
+2% +$13.4K 0.01% 428
2025
Q4
$537K Buy
1,102
+53
+5% +$24.7K ﹤0.01% 482
2025
Q3
$440K Sell
1,049
-72
-6% -$24.2K ﹤0.01% 527
2025
Q2
$322K Sell
1,121
-18
-2% -$5.38K ﹤0.01% 610
2025
Q1
$351K Sell
1,139
-13
-1% -$4.46K ﹤0.01% 595
2024
Q4
$406K Buy
1,152
+13
+1% +$4.78K ﹤0.01% 562
2024
Q3
$408K Buy
1,139
+15
+1% +$5.07K ﹤0.01% 569
2024
Q2
$358K Buy
1,124
+31
+3% +$8.21K ﹤0.01% 562
2024
Q1
$251K Sell
1,093
-196
-15% -$44.2K ﹤0.01% 666
2023
Q4
$283K Buy
1,289
+133
+12% +$30.7K ﹤0.01% 610
2023
Q3
$261K Sell
1,156
-80
-6% -$18.4K ﹤0.01% 626
2023
Q2
$273K Buy
1,236
+306
+33% +$67.8K ﹤0.01% 622
2023
Q1
$208K Buy
930
+49
+6% +$12.1K ﹤0.01% 723
2022
Q4
$245K Buy
+881
New +$222K ﹤0.01% 654
2022
Q3
Sell
-867
Closed -$204K 744
2022
Q2
$204K Buy
+867
New +$176K ﹤0.01% 671

Other funds holding UTHR